Patch
US-2015202183-A1 · Jul 23, 2015 · US
US9511051B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9511051-B2 |
| Application number | US-201314417205-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 25, 2013 |
| Priority date | Jul 26, 2012 |
| Publication date | Dec 6, 2016 |
| Grant date | Dec 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing a patch comprising a support layer and an adhesive agent layer comprises: a mixture preparation step of mixing asenapine or a pharmaceutically acceptable salt thereof with sodium acetate whose particle diameter D 50 at a cumulative volume of 50% in a particle diameter distribution is 40 to 1000 μm, in such a manner that the sodium acetate and sodium diacetate generated from the sodium acetate have a particle diameter D 50 of 10 μm or smaller, thereby obtaining a mixture containing the sodium diacetate and the asenapine or pharmaceutically acceptable salt; and an adhesive-agent-layer formation step of forming the adhesive agent layer comprising the sodium diacetate, the asenapine or pharmaceutically acceptable salt, and a pressure-sensitive adhesive base agent, by using an adhesive agent layer composition obtained by mixing the mixture with the pressure-sensitive adhesive base agent.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a patch, comprising: mixing asenapine or a pharmaceutically acceptable salt thereof with sodium acetate whose particle diameter D50 at a cumulative volume of 50% in a particle diameter distribution is in a range of 40 μm to 1000 μm, such that sodium diacetate having a particle diameter D50 of 10 μm or smaller is generated from the sodium acetate, thereby obtaining a mixture comprising the sodium diacetate and the asenapine or pharmaceutically acceptable salt; obtaining an adhesive agent layer composition by mixing the mixture and a pressure-sensitive adhesive base agent, wherein acetic acid is not added; and forming an adhesive agent layer comprising the sodium diacetate, the asenapine or pharmaceutically acceptable salt thereof, and the pressure-sensitive adhesive base agent, by applying the adhesive agent layer composition to a support layer, wherein the adhesive agent layer measured by X-ray diffraction has a peak intensity from the sodium diacetate which is higher than a peak intensity from the sodium acetate. 2. The method for producing a patch according to claim 1 , wherein the mixing comprises mixing the pharmaceutically acceptable salt of asenapine with the sodium acetate, and the pharmaceutically acceptable salt is asenapine maleate. 3. The method for producing a patch according to claim 1 , wherein the adhesive agent layer composition further comprises isopropyl palmitate. 4. The method for producing a patch according to claim 3 , wherein a mass ratio of the asenapine or pharmaceutically acceptable salt to the isopropyl palmitate where a mass of the asenapine or pharmaceutically acceptable salt is in terms of free asenapine is in a range of 1:0.1 to 1:10. 5. A patch obtained by the method of claim 1 . 6. The method for producing a patch according to claim 2 , wherein the adhesive agent layer composition further comprises isopropyl palmitate. 7. A patch obtained by the method of claim 2 . 8. A patch obtained by the method to of claim 3 . 9. A patch obtained by the method of claim 6 . 10. The method for producing a patch according to claim 1 , wherein the mixing comprises grinding mixing the asenapine or pharmaceutically acceptable salt thereof with sodium acetate. 11. The method for producing a patch according to claim 1 , wherein the mixing comprises contact mixing the asenapine or pharmaceutically acceptable salt thereof with the sodium acetate. 12. The method for producing a patch according to claim 11 , wherein the contact mixing comprises mixing the asenapine or pharmaceutically acceptable salt thereof with the sodium acetate with a propeller mixer. 13. The method for producing a patch according to claim 1 , wherein the sodium acetate and the asenapine and/or pharmaceutically acceptable salt have a mixing ratio in a range of 1.5:1 to 6:1 where the mixing ratio is a number of moles of the sodium acetate to a total number of moles of the asenapine and pharmaceutically acceptable salt. 14. The method for producing a patch according to claim 1 , wherein the sodium acetate has a content of 10% or less relative to the adhesive agent layer. 15. The method for producing a patch according to claim 1 , wherein the sodium acetate has a content of 5% or less relative to the adhesive agent layer. 16. The method for producing a patch according to claim 1 , wherein the sodium diacetate has a content in a range of 0.3% to 10% or less relative to the adhesive agent layer. 17. The method for producing a patch according to claim 1 , wherein the sodium diacetate has a content in a range of 0.5% to 6% or less relative to the adhesive agent layer. 18. The method for producing a patch according to claim 13 , wherein the sodium diacetate has a content in a range of 0.3% to 10% or less relative to the adhesive agent layer. 19. The method for producing a patch according to claim 13 , wherein the sodium diacetate has a content in a range of 0.5% to 6% or less relative to the adhesive agent layer. 20. The method for producing a patch according to claim 13 , wherein the sodium diacetate has a content in a range of 0.3% to 10% or less relative to the adhesive agent layer, and the sodium acetate has a content of 10% or less relative to the adhesive agent layer.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia · CPC title
Drugs for disorders of the nervous system · CPC title
Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title
having seven-membered rings, e.g. azelastine, pentylenetetrazole · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.